Bryant Grigsby, Phoenix DeVentures - Medical Device Innovation and Production | LSI USA '24

Bryant Grigsby  0:04  
My name is Bryant    Grigsby. I'm from Phoenix DeVentures. Unlike the rest of the speakers, I am not looking for money. So I'm a service provider and a sponsor here. So I'll spend a couple minutes talking about what we do at Phoenix DeVentures, and then go through and do the same thing introduce everybody else, Phoenix DeVentures has been around 23 years, we're a vertically integrated product development, manufacturing and sterilization firm. Sterilization is new for us. I'll talk about that in a minute. So we have a very strong track record of getting our clients successfully to market. And what I mean by that is most everybody here wants to get picked up by a strategic, our customers have been picked up by the likes of BD striker or Medtronic. See who else Bosch valiant Abbott. So we've got a nice strong track record of having our customers picked up. We've even had a couple of them go public. And to do that, we like to make sure that we're vertically integrated, we understand that it's an iterative process, we understand there's lots and lots of steps. And that it's not the technology that that fails, it's not the clinical results, typically that's fails, it's running out of money. So as a startup, everybody here is pitching and trying to get more money and time to market is critical for that. And as you go through all the different iterations, you need to be able to move fast between each of the steps. So if you have an outside molder, and you have an outside cleanroom, and you have an outside design firm, each of those handoffs takes lots and lots of time. So we have most of that in house. So we have three locations. I'll show you a map of that in a second. But we've got r&d facilities. So we've got a couple 1000 square feet of lab bench space that's highly collaborative, we have customers in our facility in our labs every single day, we have clean rooms, a lot of a lot of manufacturers will not allow you in the cleanroom, we have clean rooms that we won't allow customers to and just like everyone else, but we have a cleanroom set set aside so that our customers can be in the cleanroom doing their development, one of the things that we find extremely advantageous is to have our customers in, in our facility. And so we have three facilities. Again, I'll show you a map here in just a second. To help enable that. We've been in every part of the body. With 500 customers in the last 23 years, we've we've touched just about everything. We do manufacturing of low volume products, 25 parts a month, and we do high volume, we've got the green pen thing up on the the guess it's on your left, we've got that we run 20,000 of those a month. And so having the end to end capabilities allows us to go to whatever scale you need. As we've noticed, in the last couple of years, you used to be able to go and get acquired as soon as you have your 510 K. Now a lot of the strategics want to see successful commercialization. So we have the ability to do that. We also have a partner facility offshore if you need to actually get to higher volumes and start working those margins. The one of our big new exciting things, some of you have been following the eto issues that have been going on. So last week, the EPA did announce that they are going to be restricting the emissions on on on eto. We've been working for the last about year and a half, two years on developing a scalable Chlorine Dioxide sterilization system. So what you see there is our validation system and our generator. And that allows you as a startup to be able to go in with a small batch and go through all the validations without having to pay for a large chamber. It runs just the same as you would with an eto sterilization. It's a pure gas if you can do it with eto, generally speaking, you can do it with CD. It doesn't tend to cause lithium batteries to blow up and, and have as many issues with electronics. And so that's it's a pretty nice option. It's been around in the food industry for a very long time. It's started in the 50s in water, but it is new to medtech. It is currently a novel method and we're hoping in the not too distant future that it will turn into a class A sterilization method. We're intending on having our system internally validated by the end of April or early May. And then we'll submit all of our required documentation to the FDA and hopefully get the thumbs up here in the not too distant future to start offering commercial sterilization we are offering right now we are able to offer testing. So if you've got a product that you want to do some sanity checks and see if this modality is even feasible. We can do that. So our headquarters is in Silicon Valley in Morgan Hill, California. We've got a large r&d space and the clean rooms and moldmaking whitespace toolmaking, molding everything and, and guest cubes. And then in Lehi, Utah, we've got a smaller facility, but again, has has everything we've got a cleanroom, bubble, metal printers and an r&d space. And then in Colorado, we actually have incubator space. So if you need to rent out a space and want to have access to some labs, we've got a couple 1000 square feet of, of incubator space. And again, you know, time to market, as we all know, is the critical thing. And so having that side by side, integrated engineering, product development, manufacturing, we have folks that do the molding, looking at your product, they're gone. We hear this all the time. I printed it, it works and then the molding technicians and the molding engineers go Yeah, no. And so he skipped that iteration cycle. So we're just out here on the just in front of the the room here so you can stop by grab a brochure on sterilization if you're interested in CD sterilization.